Risk:benefit ratio of nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus

Author： Horizon Arash A   Wallace Daniel J  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.3, Iss.4, 2004-07, pp. : 273-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relationship Between Nonsteroidal Anti-inflammatory Drugs and Fall Risk in Older Adults

By Findley L. Rebekah   Bulloch Marilyn N.  

The Consultant Pharmacist, Vol. 30, Iss. 6, 2015-06 ,pp. : 346-351

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Nonsteroidal Anti-Inflammatory Drugs and Heart Failure

By Bleumink G.S.   Feenstra J.  

Drugs, Vol. 63, Iss. 6, 2003-01 ,pp. : 525-534

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Nonsteroidal Anti-Inflammatory Drugs in Synovial Fluid

By Day R.O.  

Clinical Pharmacokinetics, Vol. 36, Iss. 3, 1999-03 ,pp. : 191-210

Adis International

Access to resources Recommend Favorite

Non-steroidal anti-inflammatory drugs in cancer treatment

By Cuendet Muriel   Pezzuto John M  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 827-835

Informa Healthcare

Access to resources Recommend Favorite

Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory Drugs

By  

Current Drug Metabolism, Vol. 10, Iss. 9, 2009-11 ,pp. : 971-980

Bentham Science Publishers

Access to resources Recommend Favorite